



Age (y) 79.0 ± 8.0 80.6 ± 7.5 0.620 78.6 ± 7.6 79.7 ± 8.6 0.421 82.4 ± 4.7 83.0 ± 6.2 0.842
Education (y) 11.1 ± 1.8 9.0 ± 0.0 0.234 10.5 ± 2.3 10.3 ± 1.4 0.971 12.0 ± 3.0 10.8 ± 1.8 0.514
Clinical scores
    MMSE 19.1 ± 5.4 19.9 ± 6.3 0.600 16.9 ± 5.4 19.1 ± 4.0 0.122 20.3 ± 7.9 20.4 ± 4.4 0.336
    HDS-R 16.3 ± 6.2 16.7 ± 6.8 0.926 13.6 ± 5.9 17.2 ± 5.9 0.056 18.8 ± 8.0 20.2 ± 5.1 0.939
    GDS 6.2 ± 3.9 5.0 ± 4.5 0.354 5.6 ± 4.4 5.4 ± 3.3 0.964 6.5 ± 2.9 5.0 ± 5.2 0.578
    AS 19.8 ± 10.7 14.9 ± 10.4 0.098 18.6 ± 11.5 19.4 ± 6.3 0.297 16.4 ± 8.8 17.3 ± 7.0 0.581
    ABS 5.3 ± 5.7 3.6 ± 4.6 0.341 5.3 ± 8.2 4.7 ± 6.3 0.650 2.3 ± 3.0 6.5 ± 8.8 0.271
    ADL 16.2 ± 8.2 20.9 ± 4.4 0.276 20.4 ± 6.1 19.5 ± 5.5 0.748 20.2 ± 8.5 17.5 ± 6.1 0.256
Table 1. Baseline characteristics of each group of AD patients
Group D Group G Group R
D  → G D  → R G  → D G  → R R  → D R  → G
81.8
90 11 17 32 9 12
63.5 84.2 65.2 71.7 93.8
Abbreviations: ABS, Abe's BPSD score; AD, Alzheimer’s disease; ADL, Alzheimer’s Disease Co-operative Study - Activities of Daily Living Inventory; AS, apathy scale; D, 
Donepezil; G, Galantamine; GDS, geriatric depression scale; HDS-R, Hasegawa dementia rating scale; MMSE, mini-mental state examination; R, Revastigmine.


